NCT05232851 2026-02-10
A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer
Mayo Clinic
Phase 1/2 Completed
Mayo Clinic
Ohio State University Comprehensive Cancer Center